Li Xie

Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis

Jian Wu, X. Shen, Ningping Zhang, 2019, Laboratory Investigation.

Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis

Da Zhou, Ningping Zhang, Li Xie, 2022, Acta Pharmacologica Sinica.

Succinate‐GPR‐91 receptor signalling is responsible for nonalcoholic steatohepatitis‐associated fibrosis: Effects of DHA supplementation

A. Diehl, M. Abdelmalek, C. Niu, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Deep Convolutional Neural Network for Nasopharyngeal Carcinoma Discrimination on MRI by Comparison of Hierarchical and Simple Layered Convolutional Neural Networks

Xiaofeng Gu, Feng Xiao, Li Xie, 2022, Diagnostics.

GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses

Wei-Chang Fu, Jian Wu, B. Wu, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma

Jia Ding, Li Zhang, Yuan Zhou, 2023, Theranostics.

Succinate as a signaling molecule in the mediation of liver diseases.

Li Xie, Jian Wu, Hui Chen, 2023, Biochimica et biophysica acta. Molecular basis of disease.

JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway

Jia Ding, Yuan Zhou, Zhong-Hua Wang, 2024, Clinical and translational medicine.

GPCRs involved in metabolic diseases: pharmacotherapeutic development updates.

Yuan Zhou, Li Xie, Jian Wu, 2024, Acta pharmacologica Sinica.